Latest Prostate biopsy Stories
Outside the National Cancer Institute, LIJ is one of only two US medical centers to offer new prostate fusion biopsy technology. New Hyde Park, NY (PRWEB) May
Researchers have discovered that benign precancerous lesions detected in prostate biopsies are more likely to develop into prostate cancer for obese men compared to their normal-weight counterparts.
A genetic score based on PCa risk-associated single nucleotide polymorphisms (SNPs) is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.